Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis

Clinical Neurophysiology

Volumn 123, Issue 12, 2012, Pages 2460-2467

  Cheah, Benjamin C ^a,b   Lin, Cindy S Y ^a,d   Park, Susanna B ^a,b   Vucic, Steve ^a,c   Krishnan, Arun V ^a,d   Kiernan, Matthew C ^a,b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Amyotrophic lateral sclerosis; Biomarker; Nerve excitability; Neurophysiology

Indexed keywords

POTASSIUM CHANNEL;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ELECTRODE; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; MUSCLE ACTION POTENTIAL; NERVE EXCITABILITY; NERVE FIBER; NERVE FUNCTION; PRIORITY JOURNAL; RATING SCALE; STATISTICAL ANALYSIS;

ACTION POTENTIALS; AMYOTROPHIC LATERAL SCLEROSIS; AXONS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR NEURONS; NERVE DEGENERATION; POTASSIUM CHANNELS;

EID: 84869091794     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2012.06.020     Document Type: Article

References (35)

1. Bechtold D.A., Smith K.J. Sodium-mediated axonal degeneration in inflammatory demyelinating disease. J Neurol Sci 2005, 233:27-35.
2. Boland R.A., Bostock H., Kiernan M.C. Plasticity of lower limb motor axons after cervical cord injury. Clin Neurophysiol 2009, 120:204-209.
3. Bostock H., Cikurel K., Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998, 21:137-158.
4. Bostock H., Grafe P. Activity-dependent excitability changes in normal and demyelinated rat spinal root axons. J Physiol 1985, 365:239-257.
5. Bostock H., Sharief M.K., Reid G., Murray N.M. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 1995, 118:217-225.
6. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1:293-299.
7. Cedarbaum J.M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., et al. The ALS FRS-r: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999, 169:13-21.
8. de Carvalho M., Dengler R., Eisen A., England J.D., Kaji R., Kimura J., et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008, 119:497-503.
9. Gregory C.M., Bickel C.S. Recruitment patterns in human skeletal muscle during electrical stimulation. Phys Ther 2005, 85:358-364.
10. + channels are implicated in neuromyotonia. Ann Neurol 1997, 41:238-246.
11. Hegedus J., Putman C.T., Gordon T. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 2007, 28:154-164.
12. Huynh W., Krishnan A.V., Lin C.S., Vucic S., Kiernan M.C. The effects of large artery ischemia and subsequent recanalization on nerve excitability. Muscle Nerve 2011, 44:841-842.
13. Kanai K., Kuwabara S., Misawa S., Tamura N., Ogawara K., Nakata M., et al. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 2006, 129:953-962.
14. + conductances and neurodegeneration in amyotrophic lateral sclerosis. Exp Neurol 2009, 218:1-4.
15. Kiernan M.C., Hart I.K., Bostock H. Excitability properties of motor axons in patients with spontaneous motor unit activity. J Neurol Neurosurg Psychiatry 2001, 70:56-64.
16. Kiernan M.C., Isbister G.K., Lin C.S., Burke D., Bostock H. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 2005, 57:339-348.
17. Kiernan M.C., Lin C.S., Burke D. Differences in activity-dependent hyperpolarization in human sensory and motor axons. J Physiol 2004, 558:341-349.
18. Kiernan M.C., Vucic S., Cheah B.C., Turner M.R., Eisen A., Hardiman O., et al. Amyotrophic lateral sclerosis. Lancet 2011, 377:942-955.
19. Kollewe K., Mauss U., Krampfl K., Petri S., Dengler R., Mohammadi B. ALS FRS-r score and its ratio: a useful predictor for ALS-progression. J Neurol Sci 2008, 275:69-73.
20. Mogyoros I., Kiernan M.C., Burke D. Strength-duration properties of human peripheral nerve. Brain 1996, 119:439-447.
21. Mogyoros I., Kiernan M.C., Burke D., Bostock H. Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain 1998, 121:851-859.
22. Moldovan M., Alvarez S., Krarup C. Motor axon excitability during Wallerian degeneration. Brain 2009, 132:511-523.
23. Pieri M., Carunchio I., Curcio L., Mercuri N.B., Zona C. Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis. Exp Neurol 2009, 215:368-379.
24. Shibuya K., Misawa S., Arai K., Nakata M., Kanai K., Yoshiyama Y., et al. Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: an immunohistochemical study. Exp Neurol 2011, 232:149-153.
25. 2+ influx during anoxia in mammalian central nervous system white matter. Ann Neurol 1991, 30:375-380.
26. 2+ exchanger. J Neurosci 1992, 12:430-439.
27. + currents in human neuropathy and motor neuron disease estimated by latent addition. Clin Neurophysiol 2006, 117:2451-2458.
28. h) in human motor axons. Muscle Nerve 2010, 41:247-256.
29. Traynor B.J., Zhang H., Shefner J.M., Schoenfeld D., Cudkowicz M.E. Functional outcome measures as clinical trial endpoints in ALS. Neurology 2004, 63:1933-1935.
30. Vagg R., Mogyoros I., Kiernan M.C., Burke D. Activity-dependent hyperpolarization of human motor axons produced by natural activity. J Physiol 1998, 507:919-925.
31. van Zundert B., Peuscher M.H., Hynynen M., Chen A., Neve R.L., Brown R.H., et al. Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci 2008, 28:10864-10874.
32. Vucic S., Cheah B.C., Yiannikas C., Vincent A., Kiernan M.C. Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia. Brain 2010, 133:2727-2733.
33. Vucic S., Kiernan M.C. Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol 2006, 117:1458-1466.
34. Vucic S., Krishnan A.V., Kiernan M.C. Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007, 78:1202-1208.
35. Weiss G. Sur la possibilité de rendre compara-bles entre eux les appareils servant à l'excitation électrique. Arch Ital Biol 1901, 35:413-446.